RxDoctor Payments Data

Keith Hull

Neurology · Raleigh, NCNPI 1508896069

Payments from drug & device makers

$41,086in general payments, 2019–2025

Across 120 payments — averaging $342.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Adamas Pharmaceuticals, Inc.$18K
  • Acorda Therapeutics, Inc$17K
  • Acadia Pharmaceuticals Inc$5K
  • Sanofi$261
  • EDW Pharma, Inc.$138
  • Novartis$126
  • plus $697 from 23 others
$51,500in research payments, 2019–2025

Across 6 payments — averaging $8583.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acadia Pharmaceuticals Inc$52K

What the payments were for

  • Consulting fees$1,3654%
  • Speaking & faculty fees$30,59984%
  • Travel & lodging$2,3697%
  • Food & beverage$2,0036%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,086 in reported general payments places this provider in the 80th percentile of 566 neurology providers in North Carolina.

See all neurology providers in North Carolina

Other neurology in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →